The Bone Phenotype and Pain Response to Pamidronate in Tyrosine Kinase Inhibitor–Treated Chronic Myelogenous Leukemia

Tyrosine kinase inhibitors (TKIs) have been linked to bone pain and linear growth attenuation in children with TKI-treated chronic myelogenous leukemia (CML). We describe the skeletal phenotype in an 11-year-old boy with chronic bone pain due to TKI-treated CML, including his response to intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavoie, Declan C T, Robinson, Marie-Eve, Johnston, Donna, Pagé, Marika, Konji, Victor N, Rauch, Frank, Ward, Leanne M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462212/
https://www.ncbi.nlm.nih.gov/pubmed/30997443
http://dx.doi.org/10.1210/js.2018-00268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462212/
https://www.ncbi.nlm.nih.gov/pubmed/30997443
http://dx.doi.org/10.1210/js.2018-00268

Ejemplares similares